A Possible Role for Pioglitazone in the Management of Depressive Symptoms in Metabolic Syndrome Patients (EPICAMP Study): A Double Blind, Randomized Clinical Trial

The present trial aimed to evaluate the effects of pioglitazone on the mental status of nondiabetic metabolic syndrome patients. From 145 patients screened, 104 eligible volunteers (57% female; age 20–70 years) were enrolled and randomly assigned to receive either pioglitazone (uptitrated to 30 mg/d...

Descripción completa

Detalles Bibliográficos
Autores principales: Roohafza, Hamidreza, Shokouh, Pedram, Sadeghi, Masoumeh, Alikhassy, Zahra, Sarrafzadegan, Nizal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897538/
https://www.ncbi.nlm.nih.gov/pubmed/27433505
http://dx.doi.org/10.1155/2014/697617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897538/
https://www.ncbi.nlm.nih.gov/pubmed/27433505
http://dx.doi.org/10.1155/2014/697617

Ejemplares similares